Anti-cleaved icaspase substrate antibodies and methods of use
AssigneeGenentech, Inc.
InventorsChristopher W. DAVIES, Nobuhiko KAYAGAKI, James T. KOERBER
Life of this patent
Estimating the term…
Abstract
Provided herein are antibodies that bind to cleaved inflammatory caspase (iCaspase) substrates and methods of screening for such antibodies. Also provided herein are detection methods using such antibodies for detecting a cleaved iCaspase substrate.
Claims31
An antibody that binds to a cleaved inflammatory caspase (iCaspase) substrate, wherein the antibody specifically binds to a peptide comprising the amino acid sequence P4-P3-P2-D at the C-terminus of the peptide, wherein the antibody does not bind to peptides comprising the amino acid sequence D-X-X-D or E-X-X-D at the C-terminus, wherein X is any amino acid.
2-10. (canceled)
An antibody that binds to a cleaved inflammatory caspase (iCaspase) substrate, wherein the antibody specifically binds to a peptide comprising the amino acid sequence P4-P3-P2-D at the C-terminus of the peptide, wherein the antibody does not bind to peptides comprising the amino acid sequence D-X-X-D or E-X-X-D at the C-terminus, wherein X is any amino acid,
- wherein the antibody comprises a variable heavy chain (VH) and a variable light chain (VL), wherein the antibody comprises:
- a) a CDRH1, a CDRH2, and a CDRH3 of a VH chain comprising the amino acid sequence set forth in SEQ ID NO:
- 1 and a CDRL1, CDRL2, and CDRL3 of a VL chain comprising the amino acid sequence set forth in SEQ ID NO:
- 2, or
- b) a CDRH1, a CDRH2, and a CDRH3 of a VH chain comprising the amino acid sequence set forth in SEQ ID NO:
- 9 and a CDRL1, CDRL2, and CDRL3 of a VL chain comprising the amino acid sequences set forth in SEQ ID NO:
- 10.
(canceled)
A method of screening for an antibody that binds to a cleaved iCaspase substrate, wherein the antibody specifically binds to a peptide comprising the amino acid sequence P4-P3-P2-D at the C-terminus of the peptide, wherein the antibody does not bind to peptides comprising the amino acid sequence D-X-X-D at the C-terminus, wherein X is any amino acid, comprising
- i) providing an antibody library;
- ii) positively selecting antibodies that bind to a peptide comprising the amino acid sequence P4-P3-P2-D motif at the C-terminus;
- and
- iii) negatively selecting antibodies that bind to a peptide comprising the amino acid sequence D-X-X-D at the C-terminus,
- thereby producing an antibody that specifically binds to a peptide comprising the amino acid P4-P3-P2-D at the C-terminus, and does not bind to peptides comprising the amino acid sequence D-X-X-D at the C-terminus.
(canceled)
(canceled)
A method of detecting cleavage of an iCaspase substrate in a sample comprising
- i) contacting the sample with an anti-cleaved iCaspase substrate antibody, and
- ii) detecting a cleaved iCaspase substrate
- wherein the anti-cleaved iCaspase substrate antibody specifically binds to a peptide comprising the amino acid sequence P4-P3-P2-D at the C-terminus of the peptide, wherein the antibody does not bind to peptides comprising the amino acid sequence D-X-X-D or E-X-X-D at the C-terminus, wherein X is any amino acid.
30-31. (canceled)
A method of enriching cleaved iCaspase substrates in a sample comprising a mixture of polypeptides
- i) contacting the sample with an anti-cleaved iCaspase substrate antibody;
- and
- ii) selecting antibody-bound polypeptides from the sample,
- wherein the anti-cleaved iCaspase substrate antibody specifically binds to a peptide comprising the amino acid sequence P4-P3-P2-D at the C-terminus of the peptide, wherein the antibody does not bind to peptides comprising the amino acid sequence D-X-X-D or E-X-X-D at the C-terminus, wherein X is any amino acid.
33-34. (canceled)
A kit for detecting a cleaved iCaspase substrate in a sample comprising an anti-cleaved iCaspase substrate antibody and instructions for use, wherein the anti-cleaved iCaspase substrate antibody specifically binds to a peptide comprising the amino acid sequence P4-P3-P2-D at the C-terminus of the peptide, wherein P4 is a hydrophobic amino acid, wherein the antibody does not bind to peptides comprising the amino acid sequence D-X-X-D at the C-terminus, wherein X is any amino acid.
(canceled)
Dependencies are inferred from the claim text.